Anti-TNF-α monoclonal antibody reverses psoriasis through dual inhibition of inflammation and angiogenesis.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Immunopharmacology

• Publication date

  2015-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.intimp.2015.07.036PMID 26263167
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Curcumin relieves TPA-induced Th1 inflammation in K14-VEGF transgenic mice.

  2015cited by this paper
• NF-κB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis

  2014cited by this paper
• Immunology of psoriasis.

  2014cited by this paper
• IL-37 Ameliorates the Inflammatory Process in Psoriasis by Suppressing Proinflammatory Cytokine Production

  2014cited by this paper
• Antrodia salmonea inhibits TNF-α-induced angiogenesis and atherogenesis in human endothelial cells through the down-regulation of NF-κB and up-regulation of Nrf2 signaling pathways.

  2014cited by this paper
• Mechanisms regulating skin immunity and inflammation

  2014cited by this paper
• Diagnosis and classification of psoriasis.

  2014cited by this paper
• SOCS signaling in autoimmune diseases: Molecular mechanisms and therapeutic implications

  2014cited by this paper
• Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1/2 and EGF pathways

  2013cited by this paper
• Dermal γδ T cells--a new player in the pathogenesis of psoriasis.

  2013cited by this paper
• Psoriasis clinical implications and treatment: a review.

  2013cited by this paper
• Mice that express human interleukin-8 have increased mobilization of immature myeloid cells, which exacerbates inflammation and accelerates colon carcinogenesis.

  2012cited by this paper
• Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.

  2012cited by this paper
• MK2 posttranscriptionally regulates TNF-α-induced expression of ICAM-1 and IL-8 via tristetraprolin in human pulmonary microvascular endothelial cells.

  2012cited by this paper
• Therapeutics: Silencing psoriasis

  2012cited by this paper
• Clinical, pathological and immunological features of psoriatic-like lesions affecting keratin 14-vascular endothelial growth factor transgenic mice.

  2011cited by this paper
• Double Anti-angiogenic and Anti-inflammatory Protein Valpha Targeting VEGF-A and TNF-α in Retinopathy and Psoriasis*

  2011cited by this paper
• Innate immunity in the pathogenesis of psoriasis

  2011cited by this paper
• Epithelial and Mesenchymal Cell Biology Epidermal Vascular Endothelial Growth Factor Production Is Required for Permeability Barrier Homeostasis , Dermal Angiogenesis , and the Development of Epidermal Hyperplasia Implications for the Pathogenesis of Psoriasis

  2010cited by this paper
• Psoriasis: what we have learned from mouse models

  2010cited by this paper
• Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls.

  2010cited by this paper
• The role of angiogenesis in the pathogenesis of psoriasis

  2009cited by this paper
• Tumour necrosis factor and cancer

  2009cited by this paper
• Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis1

  2009cited by this paper
• Regulation and function of NF-kappaB transcription factors in the immune system.

  2009cited by this paper
• Key role of macrophages in the pathogenesis of CD18 hypomorphic murine model of psoriasis.

  2009cited by this paper
• Mechanisms of Disease: Psoriasis.

  2009cited by this paper
• Angiogenesis drives psoriasis pathogenesis

  2009cited by this paper
• Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis.

  2008cited by this paper
• TNFα blockade in human diseases: Mechanisms and future directions

  2008cited by this paper
• Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial.

  2008cited by this paper
• TNFalpha blockade in human diseases: mechanisms and future directions.

  2008cited by this paper
• Pathophysiology of psoriasis: Recent advances on IL-23 and Th17 cytokines

  2007cited by this paper
• Mechanisms of Disease: angiogenesis in inflammatory diseases

  2007cited by this paper
• Mouse models of psoriasis.

  2007cited by this paper
• Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation.

  2006cited by this paper
• Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation.

  2006cited by this paper
• Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model

  2005cited by this paper
• Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept.

  2005cited by this paper
• The tumour necrosis factor‐α inhibitor adalimumab rapidly reverses the decrease in epidermal Langerhans cell density in psoriatic plaques

  2005cited by this paper
• Differential Expression of Phosphorylated NF-κB/RelA in Normal and Psoriatic Epidermis and Downregulation of NF-κB in Response to Treatment with Etanercept

  2005cited by this paper
• Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.

  2004cited by this paper
• Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis.

  2003cited by this paper
• Etk/Bmx Transactivates Vascular Endothelial Growth Factor 2 and Recruits Phosphatidylinositol 3-Kinase to Mediate the Tumor Necrosis Factor-induced Angiogenic Pathway*

  2003cited by this paper
• Changing paradigms in dermatology: tumor necrosis factor alpha (TNF-alpha) blockade in psoriasis and psoriatic arthritis.

  2003cited by this paper
• Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.

  2003cited by this paper
• TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases

  2003cited by this paper
• Etk/Bmx as a Tumor Necrosis Factor Receptor Type 2-Specific Kinase: Role in Endothelial Cell Migration and Angiogenesis

  2002cited by this paper
• Extracellular regulated kinase and c-Jun N-terminal kinase are activated in psoriatic involved epidermis.

  2002cited by this paper
• Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α

  1987cited by this paper

• Hesperidin-Loaded Nanoparticles Attenuate Pathological Angiogenesis in Oxygen-Induced Retinopathy by Modulating the Retinal Immune Microenvironment.

  2026cites this paper
• Efficacy and safety of anti-inflammatory drug-assisted treatment of symptoms in patients with schizophrenia: a meta-analysis

  2026cites this paper
• Advancing psoriasis management through the application of secondary metabolites: A detailed review of phytoconstituents and their multifaceted mechanisms

  2026cites this paper
• Animal models of psoriasis for novel drug discovery: a literature update

  2025cites this paper
• Norcantharidin Inhibits an Angiogenesis of Croquel-180 Sarcomatous Cells

  2025cites this paper
• Progression of unfolded protein response and ferroptosis in angiogenesis.

  2024cites this paper
• Psoríase de novo ou exacerbação por inibidores de checkpoint PD‐1

  2024cites this paper
• Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence

  2024cites this paper
• Psoriasis de novo or exacerbation by PD-1 checkpoint inhibitors

  2024cites this paper
• Evaluation of COVID-19 Incidence in Psoriatic Patients Receiving Adalimumab

  2023cites this paper
• IL‐21 promoting angiogenesis contributes to the development of psoriasis

  2023cites this paper
• Deciphering the molecular mechanism of the THBS1 gene in the TNF signaling axis in glioma stem cells.

  2023cites this paper
• Biosimilar monoclonal antibodies in China: A patent review

  2022cites this paper
• Risk for Hepatitis B Virus Reactivation in Patients with Psoriasis Treated with Biological Agents: A Systematic Review and Meta-Analysis

  2022cites this paper
• Identification of Hub Genes and Immune Infiltration in Psoriasis by Bioinformatics Method

  2021cites this paper
• A large-scale transcriptional study reveals inhibition of COVID-19 related cytokine storm by traditional Chinese medicines

  2021cites this paper
• Luteolin attenuates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via suppression of inflammation response.

  2020cites this paper
• Immune Regulation of TNFAIP3 in Psoriasis through Its Association with Th1 and Th17 Cell Differentiation and p38 Activation

  2020cites this paper
• Dermal mesenchymal stem cells promoted adhesion and migration of endothelial cells by integrin in psoriasis

  2020cites this paper
• Tumor Necrosis Factor Alpha: Role in the Development of Obesity and Diabetes Mellitus

  2020cites this paper
• Apremilast Microemulsion as Topical Therapy for Local Inflammation: Design, Characterization and Efficacy Evaluation

  2020cites this paper
• Isolation of triterpenoids and phytosterones from Achyranthes bidentata Bl. to treat breast cancer based on network pharmacology

  2020cites this paper
• Genistein suppresses psoriasis‐related inflammation through a STAT3–NF‐&kgr;B‐dependent mechanism in keratinocytes

  2019cites this paper
• Koebner phenomenon leading to the formation of new psoriatic lesions: evidences and mechanisms

  2019cites this paper
• FGF-7 facilitates the process of psoriasis by inducing TNF-α expression in HaCaT cells.

  2019cites this paper
• IBI303, a biosimilar to adalimumab, for the treatment of patients with ankylosing spondylitis in China: a randomised, double-blind, phase 3 equivalence trial.

  2019cites this paper
• Rho-Associated Coiled-Coil Kinase (ROCK) in Molecular Regulation of Angiogenesis

  2018cites this paper
• Aliskiren: Preclinical evidence for the treatment of hyperproliferative skin disorders.

  2018cites this paper
• Mehanizmi djelovanja fenolnih kiselina na oksidacijski stres, polarizaciju makrofaga, angiogenezu i rast Ehrlichova ascitesnoga tumora

  2018cites this paper
• Anti-angiogenic effect of a humanized antibody blocking the Wnt/β-catenin signaling pathway.

  2018cites this paper
• Anti-angiogenic effects of biotechnological therapies in rheumatic diseases

  2017cites this paper
• The Role of Angiogenesis in the Development of Psoriasis

  2017cites this paper
• IL‐35 recombinant protein reverses inflammatory bowel disease and psoriasis through regulation of inflammatory cytokines and immune cells

  2017cites this paper
• Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model.

  2017cites this paper
• Morinda citrifolia lipid transfer protein 1 exhibits anti-inflammatory activity by modulation of pro- and anti-inflammatory cytokines.

  2017cites this paper
• Progress in understanding and utilizing TNF-α inhibition for the treatment of psoriatic arthritis

  2016cites this paper
• Amentoflavone protects against psoriasis-like skin lesion through suppression of NF-κB-mediated inflammation and keratinocyte proliferation

  2016cites this paper
• Novel investigational vascular endothelial growth factor (VEGF) receptor antagonists for psoriasis

  2016cites this paper
• Effects of Copper Reduction on Angiogenesis-Related Factors in Recurrent Glioblastoma Cases

  2016cites this paper
• miRNA let-7b modulates macrophage polarization and enhances tumor-associated macrophages to promote angiogenesis and mobility in prostate cancer

  2016cites this paper
• Role of the Renal Microcirculation in Progression of Chronic Kidney Injury in Obesity

  2016cites this paper
• Targeting of Tumor Necrosis Factor Alpha Receptors as a Therapeutic Strategy for Neurodegenerative Disorders

  2015cites this paper